Rifampin
- Product NDC
- 63323-351
- 11-digit product format
- 633230351
- Labeler code
- 63323
- Product ID
- 63323-351_60eb9c46-3c34-455b-a740-c03884565072
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- RIFAMPIN
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- ANDA091181
- Marketing category
- ANDA
- Marketing start
- 2014-08-21
- Substance
- RIFAMPIN
- Active strength
- 600 mg/1
- Pharmacologic classes
- Rifamycin Antibacterial [EPC], Rifamycins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rifampin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RIFAMPIN | 600 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | VJT6J7R4TR |
| Rxcui | 312821 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63323-351-20 | Rifampin | 1 in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 1 | | 8 |
| 63323-351-20 | Rifampin | 1 in 1 BOX | INJECTION, POWDER, LYOPHILIZED, | 1 | | 8 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| RIFAMPIN | ACTIVE INGREDIENT | VJT6J7R4TR | RIFAMPIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| RIFAMPIN | ACTIVE MOIETY | VJT6J7R4TR | RIFAMPIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| SODIUM FORMALDEHYDE SULFOXYLATE | INACTIVE INGREDIENT | X4ZGP7K714 | RIFAMPIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | RIFAMPIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63323-351 | RIFAMPIN (RIFAMPIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC
] | 8 | Current NDC, Legacy NDC, 2 package rows | 20221013_a1f9f1e2-dfc0-4d31-a13b-b656d897b791.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63323-351-20 | 63323035120 | 1 VIAL in 1 BOX (63323-351-20) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL | 1 vial | 2014-08-21 | 0000-00-00 | No | No | Current |